- Home
- FLC vs ARAY Comparison
FLC vs ARAY Comparison
Compare FLC & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLC | ARAY |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.5M | 170.1M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | FLC | ARAY |
|---|---|---|
| Price | $17.58 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 37.8K | ★ 1.3M |
| Earning Date | 01-01-0001 | 02-04-2026 |
| Dividend Yield | ★ 6.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $450,902,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | N/A | $4.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.51 |
| 52 Week Low | $12.62 | $0.78 |
| 52 Week High | $15.45 | $2.95 |
Technical Indicators
Market Signals| Indicator | FLC | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 35.20 |
| Support Level | $17.33 | $0.78 |
| Resistance Level | $17.60 | $0.94 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 76.67 | 22.98 |
Price Performance
Historical ComparisonAbout FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.